7751891

Source:http://linkedlifedata.com/resource/pubmed/id/7751891

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006644, umls-concept:C0034656, umls-concept:C0036525, umls-concept:C0054427, umls-concept:C0055987, umls-concept:C0075860, umls-concept:C0282461, umls-concept:C0549379, umls-concept:C1516238, umls-concept:C1521750, umls-concept:C1522484, umls-concept:C2603343
pubmed:issue	6
pubmed:dateCreated	1995-6-22
pubmed:abstractText	We sought to compare three doxorubicin-based therapies for metastatic breast cancer for response frequency, time to treatment failure (TTF), and survival.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA12011, http://linkedlifedata.com/resource/pubmed/grant/CA31983, http://linkedlifedata.com/resource/pubmed/grant/CA33601
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Fluoxymesterone, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AbramsJJ, pubmed-author:AisnerJJ, pubmed-author:BudmanDD, pubmed-author:CirrincioneCC, pubmed-author:CitronMM, pubmed-author:HollandJJ, pubmed-author:MussHH, pubmed-author:PanasciLL, pubmed-author:PerloffMM, pubmed-author:PerryMM
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	N
pubmed:pagination	1443-52
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:7751891-Adult, pubmed-meshheading:7751891-Aged, pubmed-meshheading:7751891-Aged, 80 and over, pubmed-meshheading:7751891-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7751891-Breast Neoplasms, pubmed-meshheading:7751891-Cyclophosphamide, pubmed-meshheading:7751891-Doxorubicin, pubmed-meshheading:7751891-Female, pubmed-meshheading:7751891-Fluorouracil, pubmed-meshheading:7751891-Fluoxymesterone, pubmed-meshheading:7751891-Humans, pubmed-meshheading:7751891-Methotrexate, pubmed-meshheading:7751891-Middle Aged, pubmed-meshheading:7751891-Neoplasm Recurrence, Local, pubmed-meshheading:7751891-Prednisone, pubmed-meshheading:7751891-Regression Analysis, pubmed-meshheading:7751891-Thiotepa, pubmed-meshheading:7751891-Treatment Failure, pubmed-meshheading:7751891-Vinblastine, pubmed-meshheading:7751891-Vincristine
pubmed:year	1995
pubmed:articleTitle	Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
pubmed:affiliation	University of Maryland Cancer Center, Baltimore, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III